Oncogenic Fli-1 is a potential prognostic marker for the progression of epithelial ovarian cancer

BMC Cancer

Table 2 Association between Fli-1 expression and clinicopathological parameters

Parameter	p-value (uni)	p-value (multi)	95% CI	OR
Age at diagnosis	0.848	0.485	0.70-2.13	1.22
< 50 vs ≥ 50	0.848	0.485	0.70-2.13	1.22
FIGO stage	< 0.010	< 0.010	0.12-0.52	0.25
≤II vs > II	< 0.010	< 0.010	0.12-0.52	0.25
Histological grade	0.309	0.153	0.18-1.31	0.48
G1 vs G2&G3	0.309	0.153	0.18-1.31	0.48
Lymph nodal involvement	0.015	< 0.010	0.23-0.80	0.43
Positive vs negative	0.015	< 0.010	0.23-0.80	0.43
CA125 serum level	0.006	0.013	0.04-0.68	0.16
≤ 35 U/ml vs > 35 U/ml	0.006	0.013	0.04-0.68	0.16
Residual tumor size	0.341	0.421	0.41-1.45	0.77
0 mm vs 0-10 mm	0.341	0.421	0.41-1.45	0.77
ER expression	0.575	0.425	0.46-1.39	0.80
Positive vs negative	0.575	0.425	0.46-1.39	0.80
PR expression	0.875	0.872	0.60-1.82	1.05
Positive vs negative	0.875	0.872	0.60-1.82	1.05
Her1 expression	0.228	0.230	0.80-2.58	1.43
Positive vs negative	0.228	0.230	0.80-2.58	1.43
Her2 expression	0.747	0.518	0.69-2.08	1.20
Positive vs negative	0.747	0.518	0.69-2.08	1.20
P53 expression	0.586	0.836	0.59-1.94	1.07
Positive vs negative	0.586	0.836	0.59-1.94	1.07

ISSN: 1471-2407